研究单位：[1]Vantive Health LLC[2]Beijing Chao-yang Hospital, Capital Medical University,Beijing 1816670,China,100020[3]Beijing Anzhen Hospital, Capital Medical University,Beijing 1816670,China,100029[4]Xuanwu Hospital Capital Medical University,Beijing 1816670,China,100053[5]The First Affiliated Hospital of Chongqing Medical University,Chongqing 1814906,China,400016[6]The First People''s Hospital of Guangzhou,Guangzhou 1809858,China,510180[7]Zhujiang Hospital, Southern Medical University,Guangzhou 1809858,China,510280[8]Zhejiang Provincial People''s Hospital,Hangzhou 1808926,China,310014[9]ZhongShan Hospital Fudan University,Shanghai 1796236,China,200032[10]Shanghai East Hospital,Shanghai 1796236,China,200120[11]Zhongnan Hospital, Wuhan University,Wuhan 1791247,China,430071
This is a multicenter, prospective, registry study. By collecting relevant demographic information and clinical data of patients receiving continuous renal replacement therapy (CRRT) with pre-mixed solutions, the clinical applicability of pre-mixed solutions will be evaluated in critically ill patients in real-world clinical settings. This study will be carried out in approximately 10 study sites in China. Patient data will be collected to evaluate the clinical applicability of pre-mixed solutions.
